Road to RIO-kinase 2 for AML therapy

Blood. 2022 Jan 13;139(2):156-157. doi: 10.1182/blood.2021013618.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / genetics
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Protein Kinase Inhibitors